Your browser doesn't support javascript.
loading
Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.
Basaria, Shehzad; Harman, S Mitchell; Travison, Thomas G; Hodis, Howard; Tsitouras, Panayiotis; Budoff, Matthew; Pencina, Karol M; Vita, Joseph; Dzekov, Connie; Mazer, Norman A; Coviello, Andrea D; Knapp, Philip E; Hally, Kathleen; Pinjic, Emma; Yan, Mingzhu; Storer, Thomas W; Bhasin, Shalender.
Affiliation
  • Basaria S; Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Harman SM; Kronos Longevity Research Institute, Phoenix, Arizona3Phoenix VA Health Care System, Phoenix, Arizona.
  • Travison TG; Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts11Institute for Aging Research, Hebrew SeniorLife, Boston, Mass.
  • Hodis H; Atherosclerosis Research Unit, Keck School of Medicine, University of Southern California, Los Angeles.
  • Tsitouras P; Kronos Longevity Research Institute, Phoenix, Arizona5DWR Department of Geriatric Medicine, University of Oklahoma, Oklahoma City.
  • Budoff M; Los Angeles Biomedical Research Institute, Division of Cardiology, Harbor-UCLA Medical Center, Torrance, California.
  • Pencina KM; Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Vita J; Division of Cardiology, Boston University School of Medicine, Boston, Massachusetts.
  • Dzekov C; Division of Endocrinology, Metabolism, and Molecular Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, California.
  • Mazer NA; Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland10Division of Endocrinology, Boston University School of Medicine, Boston, Massachusetts.
  • Coviello AD; Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
  • Knapp PE; Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
  • Hally K; Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Pinjic E; Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Yan M; Atherosclerosis Research Unit, Keck School of Medicine, University of Southern California, Los Angeles.
  • Storer TW; Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Bhasin S; Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
JAMA ; 314(6): 570-81, 2015 Aug 11.
Article in En | MEDLINE | ID: mdl-26262795

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testosterone / Atherosclerosis / Carotid Intima-Media Thickness Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: JAMA Year: 2015 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testosterone / Atherosclerosis / Carotid Intima-Media Thickness Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: JAMA Year: 2015 Type: Article